Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARWICK D. D., WALTON J. N. POLYMYOSITIS. Am J Med. 1963 Nov;35:646–660. doi: 10.1016/0002-9343(63)90136-0. [DOI] [PubMed] [Google Scholar]
- CASPARY E. A., GUBBAY S. S., STERN G. M. CIRCULATING ANTIBODIES IN POLYMYOSITIS AND OTHER MUSCLE-WASTING DISORDERS. Lancet. 1964 Oct 31;2(7366):941–941. doi: 10.1016/s0140-6736(64)90868-2. [DOI] [PubMed] [Google Scholar]
- CURTIS A. C., HECKAMAN J. H., WHEELER A. H. Study of the autoimmune reaction in dermatomyositis. JAMA. 1961 Nov 11;178:571–573. doi: 10.1001/jama.1961.73040450012007. [DOI] [PubMed] [Google Scholar]
- Coulson A. S., Chalmers D. G. Response of human blood lymphocytes to tuberculin PPD in tissue culture. Immunology. 1967 Apr;12(4):417–429. [PMC free article] [PubMed] [Google Scholar]
- DEEP W. D., FRAUMENI J. F., TASHIMA C. K., MCDIVITT R. LEUKOENCEPHALOPATHY AND DERMATOMYOSITIS IN HODGKIN'S DISEASE. A CASE REPORT. Arch Intern Med. 1964 May;113:635–640. doi: 10.1001/archinte.1964.00280110015003. [DOI] [PubMed] [Google Scholar]
- Dawkins R. L. Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol. 1965 Oct;90(2):619–625. doi: 10.1002/path.1700900231. [DOI] [PubMed] [Google Scholar]
- GRACE J. T., Jr, DAO T. L. Dermatomyositis in cancer: a possible etiological mechanism. Cancer. 1959 Jul-Aug;12(4):648–650. doi: 10.1002/1097-0142(195907/08)12:4<648::aid-cncr2820120404>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- Hersh E. M., Oppenheim J. J. Impaired in vitro lymphocyte transformation in Hodgkin's disease. N Engl J Med. 1965 Nov 4;273(19):1006–1012. doi: 10.1056/NEJM196511042731903. [DOI] [PubMed] [Google Scholar]
- Houseley J., Oppenheim J. J. Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis. Br Med J. 1967 Jun 10;2(5553):679–681. doi: 10.1136/bmj.2.5553.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hughes D., Caspary E. A., Field E. J. Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet. 1968 Dec 7;2(7580):1205–1207. doi: 10.1016/s0140-6736(68)91690-5. [DOI] [PubMed] [Google Scholar]
- Kakulas B. A. In vitro destruction of skeletal muscle by sensitized cells. Nature. 1966 Jun 11;210(5041):1115–1118. doi: 10.1038/2101115a0. [DOI] [PubMed] [Google Scholar]
- Logan R. G., Bandera J. M., Mikkelsen W. M., Duff I. F. Polymyositis: a clinical study. Ann Intern Med. 1966 Nov;65(5):996–1007. doi: 10.7326/0003-4819-65-5-996. [DOI] [PubMed] [Google Scholar]
- Malaviya A. N., Many A., Schwartz R. S. Treatment of dermatomyositis with methotrexate. Lancet. 1968 Aug 31;2(7566):485–488. doi: 10.1016/s0140-6736(68)90649-1. [DOI] [PubMed] [Google Scholar]
- Oppenheim J. J. Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man. Fed Proc. 1968 Jan-Feb;27(1):21–28. [PubMed] [Google Scholar]
- Rose A. L., Walton J. N. Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis. Brain. 1966 Dec;89(4):747–768. doi: 10.1093/brain/89.4.747. [DOI] [PubMed] [Google Scholar]
- SWINYARD C. A., DEAVER G. G., GREENSPAN L. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil. 1957 Sep;38(9):574–579. [PubMed] [Google Scholar]
- Winkelmann R. K., Mulder D. W., Lambert E. H., Howard F. M., Jr, Diessner G. R. Course of dermatomyositis-polymyositis: comparison of untreated and cortisone-treated patients. Mayo Clin Proc. 1968 Aug;43(8):545–556. [PubMed] [Google Scholar]